Dr. Ellen De Moll, MD

Dr. De Moll practices at Stamford Hospital in Stamford, Connecticut.

Dr. De Moll's NPI, 1518349877, was assigned on June 23, 2015. Dr. De Moll graduated from University of Connecticut School of Medicine in 2015. Dr. De Moll holds Connecticut license 64827.

Dr. De Moll's primary practice is Stamford Hospital, at 1 Hospital Plz, Stamford, CT 06902 in Western Ct County. The practice phone is (203) 276-1000.

Dr. De Moll's primary practice is Stamford Hospital in Stamford, Connecticut. Dr. De Moll is also affiliated with Stamford Hospital. The medical group on file is Dermatology Physicians of Connecticut. Dmand AI also links Dr. De Moll to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. De Moll practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. De Moll's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. De Moll is licensed in Connecticut.

CMS data shows 1,412 Medicare services from Dr. De Moll across 14 procedure codes in 2024, for 488 Medicare patients. Medicare paid $75,863 for them. Every service was in an office.

CMS counts 488 Medicare patients who saw Dr. De Moll in 2024. The largest group is 65 to 74, with 242 patients. 75% of them have high cholesterol, and 59% have high blood pressure. 4% are also on Medicaid. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. De Moll's median patient age at 57, with 66% women.

In 2024, Dr. De Moll wrote 1,100 Medicare Part D claims for 404 patients. 92% of them were for generic drugs. CMS names the drug for 966 of them, across 27 drugs with 11 or more claims each, at $291,193 in total drug cost. In 2023, CMS named 734 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. De Moll for performance year 2024, reported as part of a group. Dr. De Moll accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. De Moll as offering telehealth. CMS counts 338 procedures of skin biopsy by Dr. De Moll, more than 92% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. De Moll, published from 2013 to 2024. 2015 was the busiest year, with 3. The most frequent topics are Melanoma, Antibodies, Monoclonal, Humanized and Biomarkers, Tumor. Dr. De Moll has published most often in Cutis. Dr. De Moll's most frequent co-authors are Yvonne M. Saenger, Sebastian Gordon Bernardo, MD and Philip A. Friedlander, MD.

CMS Open Payments shows 509 general payments to Dr. De Moll from 25 drug and device companies from 2020 to 2025. Speaker and faculty fees make up the largest share, 69% of the total. UCB, Inc. paid the most, $50,850.

Dr. De Moll graduated from University of Connecticut School of Medicine in 2015.